OTC · Medical - Instruments & Supplies

Fisher & Paykel Healthcare Corporation Limited (FSPKF) Stock

$22.96 +0.26% OTC: FSPKF Healthcare

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, specializes in the global development, manufacturing, marketing, and distribution of sophisticated medical device products and systems. The company's offerings are crucial for acute and chronic respiratory care, surgical support, and the management of obstructive sleep apnea (OSA) in both clinical and home environments.

Valuation

MetricValue
Price$22.96
Market Cap$13.48B
P/E Ratio50.28
P/B Ratio11.16
P/S Ratio10.10
EPS (TTM)$0.46
52-Week High$25.69
52-Week Low$16.35
Dividend Yield2.57%

Financials & Margins

MetricValue
ROE22.84%
ROA16.42%
ROCE28.31%
Gross Margin64.16%
Operating Margin28.52%
Net Margin20.03%
Debt/Equity0.07
Current Ratio2.31

Annual Financials (USD)

Metric20222023202420252026
Revenue$1.6B$1.6B$1.8B$1.3B$2.4B
Operating Profit$509.0M$335.0M$254.0M$-371.0M$674.0M
Net Profit$377.0M$250.0M$133.0M$377.0M$473.0M
EPS$0.65$0.43$0.23$0.64$0.81
Op Margin31.0%21.1%14.5%-29.0%28.5%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$2.1B$2.2B$2.3B$2.6B$2.9B
Total Liabilities$427.0M$451.0M$523.0M$660.0M$746.0M
Cash$90.0M$121.0M$82.0M$265.0M$466.0M
Borrowings$104.0M$146.0M$189.0M$153.0M$146.0M

Latest News

SinoGuide App Launches to Provide One-Stop Digital Services for Foreign Nationals in China TMX Newsfile · Jul 23, 2026 Prediction: Meta Platforms Will Soar on July 29 When It Makes This Announcement Motley Fool · Jul 23, 2026 Uber Cuts 10% of Customer Service Staff in AI Efficiency Push BeInCrypto · Jul 23, 2026 Tenet Healthcare (THC) Reports Earnings Tomorrow: What To Expect StockStory · Jul 23, 2026 Low-Cost Developed Markets or Emerging-Market Tech Exposure? VEA vs. IEMG Motley Fool · Jul 23, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$324.0M$238.0M$430.0M$549.0M$670.0M
Investing Cash Flow$-214.0M$-57.0M$-678.0M$-206.0M$-372.0M
Financing Cash Flow$-14.0M$-14.0M$-17.0M$-18.0M$-22.0M
Net Cash Flow$-1.0M$32.0M$-36.0M$179.0M$202.0M
Free Cash Flow$155.0M$27.0M$91.0M$446.0M$495.0M

Valuation & Return Ratios

MetricValue
PEG Ratio1.41
EV / EBITDA28.54
FCF Yield2.08%
Quick Ratio1.66
Interest Coverage64.76
Return 1Y3.89%
Return 3Y61.82%
Return 5Y15.26%

Ownership

Insiders Held3.65%
Institutions Held38.02%
Institutions Float Held39.46%
Institutional HolderSharesReport Date
Pacer Advisors, Inc.4,7372026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALBBYAlibaba Health Information Technology Limited $8.60 -7.63% 24.56 $6.93B 0.00%
ALBHFAlibaba Health Information Technology Limited $0.45 +9.93% 24.85 $7.34B 24.44%
BDUUYBangkok Dusit Medical Services Public Company Limited $23.41 +0.00% 20.00 $9.30B 6.83%
CHEOFCochlear Limited $78.94 -6.84% 21.25 $5.16B 3.83%
CHEOYCochlear Limited $39.03 -6.02% 21.25 $5.11B 3.89%

About Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, specializes in the global development, manufacturing, marketing, and distribution of sophisticated medical device products and systems. The company's offerings are crucial for acute and chronic respiratory care, surgical support, and the management of obstructive sleep apnea (OSA) in both clinical and home environments. Its product portfolio features advanced solutions such as the Airvo 2 humidified high-flow nasal system, Optiflow nasal high-flow therapy, and the F&P 850 System for both non-invasive and invasive ventilation. Additionally, Fisher & Paykel Healthcare provides specialized infant respiratory products, encompassing resuscitation devices, continuous positive airway pressure (CPAP) therapy, and nasal high-flow therapy solutions for pediatric patients. The company further supplies a comprehensive range of hospital-grade items, including humidification units, breathing circuits, chambers, masks, nasal cannulas, surgical components, and various interfaces and accessories. For homecare, it offers a diverse collection of masks, CPAP machines, software for data management, humidifiers, and other related accessories. Established in 1934, Fisher & Paykel Healthcare Corporation Limited maintains its headquarters in Auckland, New Zealand.

Fisher & Paykel Healthcare Corporation Limited is headquartered in NZ.

Fisher & Paykel Healthcare Corporation Limited (FSPKF) stock trades at $22.96 with a market capitalization of $13.48B. The stock is valued at a price-to-earnings (P/E) ratio of 50.28, price-to-book of 11.16, price-to-sales of 10.10. Over the past 52 weeks the stock has ranged between $16.35 and $25.69, and currently trades 10.6% below its 52-week high. It pays a dividend yielding 2.57%.

On profitability, Fisher & Paykel Healthcare Corporation Limited generates a return on equity (ROE) of 22.84% — well above the market average, a sign of a high-quality business, return on capital employed of 28.31%, an operating margin of 28.52%, a net profit margin of 20.03%.

Official website: www.fphcare.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides